Casdin Capital and Corvex Management’s SPAC CM Life Sciences II prices upsized $240 million IPO

CM Life Sciences II, the second blank check company formed by Casdin Capital and Corvex Management targeting a life science business, raised $240 million by offering 24 million units at $10. The company offered 4 million more units than anticipated. Each unit consists of one sharRead More